title: Neuroleptic malignant syndrome-induced massive coagulopathy treated by recombinant human soluble thrombomodulin.
authors.affiliation: Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Kei
authors.initials: K
authors.lastname: Hayashida
authors.forename: Seitaro
authors.initials: S
authors.lastname: Fujishima
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Nakaya
authors.forename: Shinya
authors.initials: S
authors.lastname: Abe
authors.forename: Akiko
authors.initials: A
authors.lastname: Shiroshita-Takeshita
authors.forename: Shingo
authors.initials: S
authors.lastname: Hori
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000009:adverse effects*; D009459:Neuroleptic Malignant Syndrome / Q000150:complications* / Q000175:diagnosis; D011994:Recombinant Proteins / Q000627:therapeutic use; D018180:Thrombomodulin / Q000627:therapeutic use*
chemical_list: C472045:ART123; D000925:Anticoagulants; D014150:Antipsychotic Agents; D011994:Recombinant Proteins; D018180:Thrombomodulin; D008728:Methotrimeprazine